Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects

American Journal of Epidemiology

Volumn 149, Issue 7, 1999, Pages 621-629

  Yu, Ming Whei ^a   Chiu, Yueh Hsia ^a   Chiang, Yi Ching ^a   Chen, Chien Hung ^b   Lee, Tzong Hsi ^b   Santella, Regina M ^c   Chern, Herng Der ^d   Liaw, Yun Fan ^e   Chen, Chien Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Alcohol drinking; Carcinoma, hepatocellular; Carotene; Glutathione transferases; Smoking

Indexed keywords

ALCOHOL; ALPHA CAROTENE; BETA CAROTENE; CAROTENOID; CIGARETTE SMOKE; GLUTATHIONE TRANSFERASE; LYCOPENE;

ARTICLE; CANCER RISK; CHRONIC HEPATITIS; CIGARETTE SMOKING; DISEASE ASSOCIATION; DOSE RESPONSE; DRINKING BEHAVIOR; ENVIRONMENTAL EXPOSURE; ENZYME BLOOD LEVEL; GENETIC POLYMORPHISM; HEPATITIS B; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SMOKING; TAIWAN; VIRUS CARRIER; VITAMIN BLOOD LEVEL;

EID: 0033119878     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009862     Document Type: Article

References (39)

1. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994;17:71-91.
2. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
3. Yu MW, You SL, Chang AS, et al. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5.
4. Chen CJ, Yu MW, Liaw YF, et al. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet 1996;59:128-34.
5. Yu MW, Lien JP, Chiu YH, et al. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol 1997;27:320-30.
6. Ross RK, Yuan JM, Yu MC, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-6.
7. Yu MC, Tong MJ, Govindarajan S, et al. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
8. Chen CJ, Liang KY, Chang AS, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991;13: 398-406.
9. Tsukuma H, Hiyama T, Oshima A, et al. A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 1990;45:231-6.
10. Yu MW, Gladek-Yarborough A, Chiamprasert S, et al. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995;109:1266-73.
11. Trichopoulos D, Day NE, Kaklamani E, et al. Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma. Int J Cancer 1987;39:45-9.
12. Frei B, ed. Natural antioxidants in human health and disease. San Diego: Academic Press, 1994.
13. Yu MW, Hsieh HH, Pan WH, et al. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res 1995;55:1301-5.
14. La Vecchia C, Negri E, Decarli A, et al. Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 1988;42:872-6.
15. Kawajiri K, Nakachi K, Imai K, et al. The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol 1993;14:77-87.
16. Brockmöller J, Cascorbi I, Kerb R, et al. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996;56:3915-25.
17. McWilliams JE, Sanderson BJS, Harris EL, et al. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1995;4:589-94.
18. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;61: 733-43.
19. Deakin M, Elder J, Hendrickse C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 1996;17:881-4.
20. Bell DA, Taylor JA, Paulson DF, et al. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
21. Hirvonen A, Pelin K, Tammilehto L, et al. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 1995;55:2981-3.
22. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
23. Miller KW, Yang CS. An isocratic high-performance liquid chromatography method for the simultaneous analysis of plasma retinol, α-tocopherol, and various carotenoids. Anal Biochem 1985;145:21-6.
24. Murakoshi M, Nishino H, Satomi Y, et al. Potent preventive action of α-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by α-carotene than by β-carotene. Cancer Res 1992;52:6583-7.
25. Bertram JS, Pung A, Churley M, et al. Diverse carotenoids protect against chemically induced neoplastic transformation. Carcinogenesis 1991;12:671-8.
26. Zhang LX, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991;12:2109-14.
27. Shekelle RB, Lepper M, Liu S, et al. Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet 1981;2:1185-90.
28. LeMarchand L, Yoshizawa CN, Kolonel LN, et al. Vegetable consumption and lung cancer risk: a population-based case-control study in Hawaii. J Natl Cancer Inst 1989;81:1158-64.
29. Ziegler RG, Colavito EA, Hartge P, et al. Importance of α-carotene, β-carotene, and other phytochemicals in the etiology of lung cancer. J Natl Cancer Inst 1996;88:612-15.
30. Mackerras D, Buffler PA, Randall DE, et al. Carotene intake and the risk of laryngeal cancer in coastal Texas. Am J Epidemiol 1988;128:980-8.
31. McLaughlin JK, Gridley G, Block G, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988;80:1237-43.
32. Comstock GW, Bush TL, Helzlsouer K. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992;135:115-21.
33. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
34. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
35. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
36. 1 binding to DNA in woodchuck hepatocytes. Cancer 1994;73:596-604.
37. 1-DNA adducts in healthy males. Carcinogenesis 1997;18:1189-94.
38. Lieber CS, Garro A, Leo MA, et al. Alcohol and cancer Hepatology 1986;6:1005-19.
39. Cooper CS, Grover PL, eds. Chemical carcinogenesis and mutagenesis I. New York: Springer-Verlag, 1990.